Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00433355 · ClinicalTrials.gov registry record
Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome
A clinical trial of Chronic Fatigue Syndrome, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT00433355: Completed study of Chronic Fatigue Syndrome, sponsored by University of Mississippi Medical Center.
NCT00433355 is a study of Chronic Fatigue Syndrome that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 15 participants, below the 7,247-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00433355, a study of Chronic Fatigue Syndrome, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand what causes a continuing fatigue for a long time with a number of symptoms occurring at the same time (Chronic Fatigue Syndrome-CFS). Epstein Barr Virus is among the group of viruses that have been associated with a continuing fatigue for a long time with a number of symptoms occurring at the same time, but the cause is still unknown.
Conditions Studied
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-10 |
What the finished NCT00433355 record still lists
NCT00433355 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 7,247-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Chronic Fatigue Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00433355 reports a single indexed study location in Mississippi.
Frequently Asked Questions
What is clinical trial NCT00433355 about?
NCT00433355 is a clinical study titled "Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome". The purpose of this study is to understand what causes a continuing fatigue for a long time with a number of symptoms occurring at the same time (Chronic Fatigue Syndrome-CFS). Epstein Barr Virus is among the group of viruses that have been associated with a continuing fatigue for a long time with a...
What is the current status of trial NCT00433355?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2007-01. Estimated completion is 2008-10.
What conditions does trial NCT00433355 study?
This clinical trial studies the following conditions: Chronic Fatigue Syndrome.
Who is sponsoring clinical trial NCT00433355?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00433355 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Fatigue Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00433355's enrollment target sits among peer trials
15 14th of 14 higher than 1 of 14 other Chronic Fatigue Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Fatigue Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
RECRUITING · Phase 1
-
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
RECRUITING · Phase 2
-
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
RECRUITING · NA
-
tVNS in Long COVID-19
RECRUITING · NA
-
The Long COVID-19 Wearable Device Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia